Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples